New Delhi, March 31 (PTI): India’s drug regulator Drugs Controller General of India has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date.
In a letter to the Serum Institute of India, Drugs Controller General of India V G Somani said the SII is permitted to apply the shelf life of nine months to unlabelled vials available on hand.
The DCGI said it has no objection in respect of ‘Extension of Shelf Life of Covishield Vaccine’ in multi-dose glass vial (10 dose-5ml) from six months to nine months.
“You are permitted to apply the shelf life of nine months to unlabelled vials available on hand, subject to the condition that the details of such stock, batch-wise, shall be submitted to this office and Central Drugs Laboratory, Kasauli,” Somani said in the letter.
The last Konyak headhunters of Nagaland
The Top Viral YouTube Videos of 2017
Meet R.N. Ravi, who is mediating peace with the Nagas
What Does Your Face Say About Your Health?
Leave a Reply
Your email address will not be published. Required fields are marked (required)